CellaVision
211,5
SEK
-2,76 %
CEVI
NASDAQ Stockholm
Medical Equipment & Services
Health Care
1.501 investorer følger denne virksomhed
-2,76%
-2,76%
-3,2%
-26,69%
-15,06%
-0,24%
-34,96%
-33,8%
+1.255,77%
CellaVision is active in medical technology. The company's operations develop and market image analysis systems for diagnosing blood and other body fluids. The products are intended to replace traditional microscope analysis. Operations are conducted on a global level, primarily in the Nordic countries, Europe and North America, where customers consist of research institutes. The head office is located in Lund.
Læs mereMarkedsværdi
5,04 mia. SEK
Aktieomsætning
4,8 mio. SEK
Omsætning
677,29 mio.
EBIT %
24,66 %
P/E
38,74
Udbytteafkast, %
1,06 %
Finanskalender
6.2
2025
Årsrapport '24
29.4
2025
Delårsrapport Q1'25
6.5
2025
Generalforsamling '24
ViserAlle indholdstyper
Redeye: Cellavision Q3’2024 - Underlying momentum intact
CellaVision, Audiocast with teleconference, Q3'24
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools